ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1010

Bone Loss Before Clinical Onset of Rheumatoid Arthritis o Subjects with Anti-Citrullinated Protein Antibodies

Stephanie Finzel1, Veronika Lang2, Arnd Kleyer1, Juergen Rech3, Bernhard Manger1, Elizabeth Araujo1, Axel J. Hueber4, Ulrike Harre5 and Georg Schett1, 1Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Dept. of Medicine, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Germany, 3Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 4Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 5Institute for Clinical Immunology, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: anti-CCP antibodies, anti-citrullinated protein/peptide antibodies (ACPA), Bone density, computed tomography (CT) and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Session Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging, Computed Tomography and X-ray

Session Type: Abstract Submissions (ACR)

Background/Purpose: Anti-citrullinated protein antibodies (ACPA) are a major risk factor for rapid disease progression in rheumatoid arthritis (RA). We have recently shown that ACPA directly induce bone loss by stimulating osteoclast differentiation (Harre et al, J Clin Invest 2012;122:1791). As ACPA precede the clinical onset of RA we hypothesized that ACPA positive healthy individuals may shows skeletal changes.

Methods: performed a comparative micro computed tomography analysis of the bone microstructure in the metacarpophalangeal joints (MCPJ) of ACPA positive and -negative healthy individuals without signs of arthritis.

Results:

ACPA positive (N= 10) and -negative (N= 10) healthy individuals were not different in age (48.2 ± 4.1 vs. 51.4 ± 3.8 years, p = 0.57) and gender (each 8 females and 2 males). Bone minaral density was significantly reduced in ACPA-positive individuals (mean  ± SEM: 280 ± 11 mg/ccm) as compared to controls (327 ± 6 mg/ccm). Bone loss was based on cortical bone changes with significant (p = 0.044) reduction in cortical thickness in the ACPA-positive group (mean  ± SEM: 0.22 ± 0.03 mm) as compared to controls (0.32 ± 0.03 mm).

Conclusion:

Structural bone damage starts before the clinical onset of arthritis in subjects with ACPA. These findings revise the concept of bone damage as an exclusive consequence of synovitis in ACPA positive individuals.


Disclosure:

S. Finzel,
None;

V. Lang,
None;

A. Kleyer,
None;

J. Rech,
None;

B. Manger,
None;

E. Araujo,
None;

A. J. Hueber,
None;

U. Harre,
None;

G. Schett,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-loss-before-clinical-onset-of-rheumatoid-arthritis-o-subjects-with-anti-citrullinated-protein-antibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences